Logo image of ERA.PA

ERAMET (ERA.PA) Stock Fundamental Analysis

EPA:ERA - Euronext Paris - Matif - FR0000131757 - Common Stock - Currency: EUR

61.2  -1.45 (-2.31%)

Fundamental Rating

4

ERA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 37 industry peers in the Metals & Mining industry. There are concerns on the financial health of ERA while its profitability can be described as average. ERA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ERA has reported negative net income.
In the past year ERA has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: ERA reported negative net income in multiple years.
In the past 5 years ERA always reported a positive cash flow from operatings.
ERA.PA Yearly Net Income VS EBIT VS OCF VS FCFERA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B

1.2 Ratios

ERA has a Return On Assets of -0.44%. This is in the lower half of the industry: ERA underperforms 64.86% of its industry peers.
ERA's Return On Equity of -1.88% is on the low side compared to the rest of the industry. ERA is outperformed by 64.86% of its industry peers.
The Return On Invested Capital of ERA (1.55%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for ERA is significantly above the industry average of 6.33%.
The 3 year average ROIC (11.73%) for ERA is well above the current ROIC(1.55%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.44%
ROE -1.88%
ROIC 1.55%
ROA(3y)5.62%
ROA(5y)0.67%
ROE(3y)25.94%
ROE(5y)-4.74%
ROIC(3y)11.73%
ROIC(5y)8.92%
ERA.PA Yearly ROA, ROE, ROICERA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60 -80

1.3 Margins

ERA's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 3.68%, ERA perfoms like the industry average, outperforming 40.54% of the companies in the same industry.
In the last couple of years the Operating Margin of ERA has declined.
ERA has a Gross Margin of 66.44%. This is amongst the best in the industry. ERA outperforms 89.19% of its industry peers.
ERA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.68%
PM (TTM) N/A
GM 66.44%
OM growth 3Y-25.05%
OM growth 5Y-24.15%
PM growth 3YN/A
PM growth 5Y18.7%
GM growth 3Y-1.38%
GM growth 5Y19.66%
ERA.PA Yearly Profit, Operating, Gross MarginsERA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

3

2. Health

2.1 Basic Checks

ERA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ERA has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ERA has more shares outstanding
Compared to 1 year ago, ERA has a worse debt to assets ratio.
ERA.PA Yearly Shares OutstandingERA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
ERA.PA Yearly Total Debt VS Total AssetsERA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

ERA has an Altman-Z score of 1.31. This is a bad value and indicates that ERA is not financially healthy and even has some risk of bankruptcy.
ERA has a worse Altman-Z score (1.31) than 67.57% of its industry peers.
A Debt/Equity ratio of 1.27 is on the high side and indicates that ERA has dependencies on debt financing.
ERA's Debt to Equity ratio of 1.27 is on the low side compared to the rest of the industry. ERA is outperformed by 81.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACC0.17
WACC9.21%
ERA.PA Yearly LT Debt VS Equity VS FCFERA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B

2.3 Liquidity

A Current Ratio of 2.08 indicates that ERA has no problem at all paying its short term obligations.
The Current ratio of ERA (2.08) is better than 75.68% of its industry peers.
A Quick Ratio of 1.66 indicates that ERA should not have too much problems paying its short term obligations.
ERA has a better Quick ratio (1.66) than 81.08% of its industry peers.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 1.66
ERA.PA Yearly Current Assets VS Current LiabilitesERA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

4

3. Growth

3.1 Past

The earnings per share for ERA have decreased strongly by -119.24% in the last year.
The Earnings Per Share has been growing by 15.49% on average over the past years. This is quite good.
ERA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.19%.
Measured over the past years, ERA shows a decrease in Revenue. The Revenue has been decreasing by -2.69% on average per year.
EPS 1Y (TTM)-119.24%
EPS 3YN/A
EPS 5Y15.49%
EPS Q2Q%-142.48%
Revenue 1Y (TTM)-22.19%
Revenue growth 3Y5.2%
Revenue growth 5Y-2.69%
Sales Q2Q%-9.48%

3.2 Future

The Earnings Per Share is expected to grow by 26.76% on average over the next years. This is a very strong growth
Based on estimates for the next years, ERA will show a small growth in Revenue. The Revenue will grow by 3.39% on average per year.
EPS Next Y-35.51%
EPS Next 2Y2.24%
EPS Next 3Y26.76%
EPS Next 5YN/A
Revenue Next Year-9.72%
Revenue Next 2Y-1.16%
Revenue Next 3Y3.36%
Revenue Next 5Y3.39%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ERA.PA Yearly Revenue VS EstimatesERA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ERA.PA Yearly EPS VS EstimatesERA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ERA. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 9.00, the valuation of ERA can be described as very reasonable.
Based on the Price/Forward Earnings ratio, ERA is valued a bit cheaper than the industry average as 75.68% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.10. ERA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 9
ERA.PA Price Earnings VS Forward Price EarningsERA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

83.78% of the companies in the same industry are more expensive than ERA, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.37
ERA.PA Per share dataERA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80 100

4.3 Compensation for Growth

A more expensive valuation may be justified as ERA's earnings are expected to grow with 26.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.24%
EPS Next 3Y26.76%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.39%, ERA has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.77, ERA pays a bit more dividend than its industry peers.
ERA's Dividend Yield is comparable with the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 2.39%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ERA.PA Yearly Dividends per shareERA.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 1 2 3

5.3 Sustainability

DP0%
EPS Next 2Y2.24%
EPS Next 3Y26.76%
ERA.PA Yearly Income VS Free CF VS DividendERA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M

ERAMET

EPA:ERA (3/7/2025, 7:00:00 PM)

61.2

-1.45 (-2.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)04-24 2025-04-24
Inst Owners11.15%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap1.76B
Analysts80
Price Target84.15 (37.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.39%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.2%
PT rev (3m)-4.07%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-38.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9
P/S 0.57
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 1.53
EV/EBITDA 4.37
EPS(TTM)-1.07
EYN/A
EPS(NY)6.8
Fwd EY11.11%
FCF(TTM)-22.84
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS107.75
BVpS55.39
TBVpS39.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.44%
ROE -1.88%
ROCE 2.14%
ROIC 1.55%
ROICexc 2.19%
ROICexgc 2.48%
OM 3.68%
PM (TTM) N/A
GM 66.44%
FCFM N/A
ROA(3y)5.62%
ROA(5y)0.67%
ROE(3y)25.94%
ROE(5y)-4.74%
ROIC(3y)11.73%
ROIC(5y)8.92%
ROICexc(3y)17.25%
ROICexc(5y)12.97%
ROICexgc(3y)20.4%
ROICexgc(5y)15.29%
ROCE(3y)16.5%
ROCE(5y)12.5%
ROICexcg growth 3Y-19.97%
ROICexcg growth 5Y-24.81%
ROICexc growth 3Y-19.75%
ROICexc growth 5Y-24.91%
OM growth 3Y-25.05%
OM growth 5Y-24.15%
PM growth 3YN/A
PM growth 5Y18.7%
GM growth 3Y-1.38%
GM growth 5Y19.66%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Debt/EBITDA 4.61
Cap/Depr 202.16%
Cap/Sales 21.14%
Interest Coverage 0.66
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.08
Quick Ratio 1.66
Altman-Z 1.31
F-Score3
WACC9.21%
ROIC/WACC0.17
Cap/Depr(3y)182%
Cap/Depr(5y)147.41%
Cap/Sales(3y)13.6%
Cap/Sales(5y)13.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-119.24%
EPS 3YN/A
EPS 5Y15.49%
EPS Q2Q%-142.48%
EPS Next Y-35.51%
EPS Next 2Y2.24%
EPS Next 3Y26.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.19%
Revenue growth 3Y5.2%
Revenue growth 5Y-2.69%
Sales Q2Q%-9.48%
Revenue Next Year-9.72%
Revenue Next 2Y-1.16%
Revenue Next 3Y3.36%
Revenue Next 5Y3.39%
EBIT growth 1Y-72.6%
EBIT growth 3Y-21.15%
EBIT growth 5Y-26.19%
EBIT Next Year181.88%
EBIT Next 3Y68.43%
EBIT Next 5YN/A
FCF growth 1Y-267.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-100.24%
OCF growth 3Y-12.93%
OCF growth 5Y-14.13%